227 related articles for article (PubMed ID: 15120879)
1. Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses?
Watts GF
Eur Heart J; 2004 May; 25(9):716-9. PubMed ID: 15120879
[No Abstract] [Full Text] [Related]
2. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
[TBL] [Abstract][Full Text] [Related]
3. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
März W
MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
[No Abstract] [Full Text] [Related]
4. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
Devroey D; Velkeniers B; Duquet W; Betz W
Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669
[TBL] [Abstract][Full Text] [Related]
5. Pravastatin and coronary heart disease.
Meyer FP
N Engl J Med; 1999 Apr; 340(14):1115-6; author reply 1116-7. PubMed ID: 10206830
[No Abstract] [Full Text] [Related]
6. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
Windler E
Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000
[No Abstract] [Full Text] [Related]
7. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
8. Achieving lipid goals in real life: the Dutch DISCOVERY study.
Bots AF; Kastelein JJ;
Int J Clin Pract; 2005 Dec; 59(12):1387-94. PubMed ID: 16351669
[TBL] [Abstract][Full Text] [Related]
9. Who should receive statin therapy among the elderly?
Desilvey DL
Am J Geriatr Cardiol; 2006; 15(2):122. PubMed ID: 16525228
[No Abstract] [Full Text] [Related]
10. Pravastatin and coronary heart disease.
Bloom JM
N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
[No Abstract] [Full Text] [Related]
11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
12. Optimal lipids, statins, and dementia.
Lavie CJ; Milani RV
J Am Coll Cardiol; 2005 Mar; 45(6):963-4; author reply 964-5. PubMed ID: 15766838
[No Abstract] [Full Text] [Related]
13. Benefits of the statins: beyond cholesterol.
Harv Mens Health Watch; 2001 Aug; 6(1):1-5. PubMed ID: 11546633
[No Abstract] [Full Text] [Related]
14. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
15. Clinical inquiries. What is the target for low-density lipoprotein cholesterol in patients with heart disease?
Stevermer JJ; Meadows SE
J Fam Pract; 2002 Oct; 51(10):893. PubMed ID: 12401164
[No Abstract] [Full Text] [Related]
16. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
17. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
18. [Stroke, cholesterol and statins--are there new data about stroke prevention?].
Ferbert A
Dtsch Med Wochenschr; 2001 Jun; 126(22):664-70. PubMed ID: 11450627
[No Abstract] [Full Text] [Related]
19. Functional evaluation of lipid-lowering therapy by pravastatin.
Schoebel FC; Jax TW; Strauer BE; Leschke M
Circulation; 1998 May; 97(18):1874-5. PubMed ID: 9603548
[No Abstract] [Full Text] [Related]
20. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
